Diabetic Schwann cells suffer from nerve growth factor and neurotrophin-3 underproduction and poor associability with axons

GLIA

Volumn 61, Issue 12, 2013, Pages 1990-1999

  Dey, Indranil ^a   Midha, Nisha ^a   Singh, Geeta ^a   Forsyth, Amanda ^a   Walsh, Sarah K ^a   Singh, Bhagat ^a   Kumar, Ranjan ^a   Toth, Cory ^a   Midha, Rajiv ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diabetic peripheral neuropathy; Insulin; Neurotrophins; Schwann cells

Indexed keywords

INSULIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEUROPATHY; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MALE; MICROENVIRONMENT; MOUSE; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE CONDUCTION; NERVE FIBER; NERVE FIBER REGENERATION; NERVE GROWTH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCHWANN CELL; SCIATIC NERVE; STREPTOZOCIN DIABETES;

DIABETIC PERIPHERAL NEUROPATHY; INSULIN; NEUROTROPHINS; SCHWANN CELLS;

ANIMALS; AXONS; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HYPERGLYCEMIA; INSULIN; MICE; NERVE GROWTH FACTOR; NERVE REGENERATION; NEUROTROPHIN 3; SCHWANN CELLS; SCIATIC NERVE;

EID: 84886640895     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22570     Document Type: Article

References (61)

1. Amin DN, Tuck D, Stern DF. 2005. Neuregulin-regulated gene expression in mammary carcinoma cells. Exp Cell Res 309:12-23.
2. Andreassen CS, Jakobsen J, Flyvbjerg A, Andersen H. 2009. Expression of neurotrophic factors in diabetic muscle-relation to neuropathy and muscle strength. Brain 132(Pt 10):2724-2733.
3. Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ. 2000. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 1:2215-2221.
4. Arthur-Farraj P, Wanek K, Hantke J, Davis CM, Jayakar A, Parkinson DB, Mirsky R, Jessen KR. 2011. Mouse schwann cells need both NRG1 and cyclic AMP to myelinate. Glia 59:720-733.
5. Askwith T, Zeng W, Eggo MC, Stevens MJ. 2009. Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy. Am J Physiol Endocrinol Metab 297:E620-E628.
6. Bhatheja K, Field J. 2006. Schwann cells: Origins and role in axonal maintenance and regeneration. Int J Biochem Cell Biol 38:1995-1999.
7. Brussee V, Cunningham FA, Zochodne DW. 2004. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53:1824-1830.
8. Carson KA, Bossen EH, Hanker JS. 1980. Peripheral neuropathy in mouse hereditary diabetes mellitus. II. Ultrastructural correlates of degenerative and regenerative changes. Neuropathol Appl Neurobiol 6:361-374.
9. Chang IA, Oh MJ, Kim MH, Park SK, Kim BG, Namgung U. 2012. Vimentin phosphorylation by Cdc2 in Schwann cell controls axon growth via beta1-integrin activation. FASEB J 26:2401-2413.
10. Cornejo M, Nambi D, Walheim C, Somerville M, Walker J, Kim L, Ollison L, Diamante G, Vyawahare S, de Bellard ME. 2010. Effect of NRG1, GDNF, EGF and NGF in the migration of a Schwann cell precursor line. Neurochem Res 35:1643-1651.
11. Delaney CL, Russell JW, Cheng HL, Feldman EL. 2001. Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. J Neuropathol Exp Neurol 60:147-160.
12. Eckersley L. 2002. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol 50:293-321.
13. Eckersley L, Ansselin AD, Tomlinson DR. 2001. Effects of experimental diabetes on axonal and Schwann cell changes in sciatic nerve isografts. Brain Res Mol Brain Res 92:128-137.
14. Francis G, Martinez J, Liu W, Nguyen T, Ayer A, Fine J, Zochodne D, Hanson LR, Frey WH II, Toth C. 2009. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes 58:934-945.
15. Frostick SP, Yin Q, Kemp GJ. 1998. Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery 18:397-405.
16. Giannini C, Dyck PJ, Thomas PK. 1999. Pathological alterations in human diabetic polyneuropathy. Diabetic Neuropathy. Philadelphia, W.B. Saunders 2:279-296.
17. Hainfellner JA, Voigtlander T, Strobel T, Mazal PR, Maddalena AS, Aguzzi A, Budka H. 2001. Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. J Neuropathol Exp Neurol 60:449-461.
18. Hashimoto R, Udagawa J, Kagohashi Y, Matsumoto A, Hatta T, Otani H. 2011. Direct and indirect effects of neuropeptide Y and neurotrophin 3 on myelination in the neonatal brains. Brain Res 1373:55-66.
19. Hoke A. 2006. Neuroprotection in the peripheral nervous system: Rationale for more effective therapies. Arch Neurol 63:1681-1685.
20. Hu J, Zhou J, Li X, Wang F, Lu H. 2011. Schwann cells promote neurite outgrowth of dorsal root ganglion neurons through secretion of nerve growth factor. Indian J Exp Biol 49:177-182.
21. Ihnat MA, Thorpe JE, Kamat CD, Szabo C, Green DE, Warnke LA, Lacza Z, Cselenyak A, Ross K, Shakir S, Piconi L, Kaltreider RC, Ceriello A. 2007. Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia 50:1523-1531.
22. Islam MS, Loots du T. 2009. Experimental rodent models of type 2 diabetes: A review. Methods Find Exp Clin Pharmacol 31:249-261.
23. Jessen KR, Mirsky R. 2008. Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 56:1552-1565.
24. Kamiya H, Zhang W, Sima AA. 2004. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes. Ann Neurol 56:827-835.
25. Karamoysoyli E, Burnand RC, Tomlinson DR, Gardiner NJ. 2008. Neuritin mediates nerve growth factor-induced axonal regeneration and is deficient in experimental diabetic neuropathy. Diabetes 57:181-189.
26. Keswani SC, Buldanlioglu U, Fischer A, Reed N, Polley M, Liang H, Zhou C, Jack C, Leitz GJ, Hoke A. 2004. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration 16821. Ann Neurol 56:815-826.
27. Kusano K, Enomoto M, Hirai T, Tsoulfas P, Sotome S, Shinomiya K, Okawa A. 2010. Transplanted neural progenitor cells expressing mutant NT3 promote myelination and partial hindlimb recovery in the chronic phase after spinal cord injury. Biochem Biophys Res Commun 393:812-817.
28. Leinninger GM, Vincent AM, Feldman EL. 2004. The role of growth factors in diabetic peripheral neuropathy. J Peripheral Nervous Syst 9:26-53.
29. Liu N, Varma S, Tsao D, Shooter EM, Tolwani RJ. 2007. Depleting endogenous neurotrophin-3 enhances myelin formation in the Trembler-J mouse, a model of a peripheral neuropathy. J Neurosci Res 85:2863-2869.
30. Ma Z, Wang J, Song F, Loeb JA. 2011. Critical period of axoglial signaling between neuregulin-1 and brain-derived neurotrophic factor required for early Schwann cell survival and differentiation. J Neurosci 31:9630-9640.
31. Mirsky R, Jessen KR. 1999. The neurobiology of schwann cells. Brain Pathol 9:293-311.
32. Morgan L, Jessen KR, Mirsky R. 1991. The effects of cAMP on differentiation of cultured Schwann cells: Progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition. J Cell Biol 112:457-467.
33. Nickols JC, Valentine W, Kanwal S, Carter BD. 2003. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 6:161-167.
34. Obrosova IG, Fathallah L, Stevens MJ. 2001. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp Neurol 172:211-219.
35. Ohi T, Saita K, Furukawa S, Ohta M, Hayashi K, Matsukura S. 1998. Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor. Exp Neurol 151:215-220.
36. Padilla A, Descorbeth M, Almeyda AL, Payne K, De Leon M. 2011. Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity. Brain Res 1370:64-79.
37. Parrinello S, Noon LA, Harrisingh MC, Digby PW, Rosenberg LH, Cremona CA, Echave P, Flanagan AM, Parada LF, Lloyd AC. 2008. NF1 loss disrupts Schwann cell-axonal interactions: A novel role for semaphorin 4F. Genes Dev 22:3335-3348.
38. Sahenk Z, Oblinger J, Edwards C. 2008. Neurotrophin-3 deficient Schwann cells impair nerve regeneration. Exp Neurol 212:552-556.
39. Shettar A, Muttagi G. 2012. Developmental regulation of insulin receptor gene in sciatic nerves and role of insulin on glycoprotein P0 in the Schwann cells. Peptides 36:46-53.
40. Shetter AR, Muttagi G, Sagar CB. 2011. Expression and localization of insulin receptors in dissociated primary cultures of rat Schwann cells. Cell Biol Int 35:299-304.
41. Singh B, Xu Y, McLaughlin T, Singh V, Martinez JA, Krishnan A, Zochodne DW. 2012. Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin. J Neurochem 121:263-276.
42. Sinnreich M, Taylor BV, Dyck PJ. 2005. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist 11:63-79.
43. Stewart HJ, Eccleston PA, Jessen KR, Mirsky R. 1991. Interaction between cAMP elevation, identified growth factors, and serum components in regulating Schwann cell growth. J Neurosci Res 30:346-352.
44. Sugimoto K, Murakawa Y, Sima AA. 2002. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripheral Nervous Syst 7:44-53.
45. Suzuki T, Sekido H, Kato N, Nakayama Y, Yabe-Nishimura C. 2004. Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: Involvement of the polyol pathway. J Neurochem 91:1430-1438.
46. Tan W, Rouen S, Barkus KM, Dremina YS, Hui D, Christianson JA, Wright DE, Yoon SO, Dobrowsky RT. 2003. Nerve growth factor blocks the glucose-induced down-regulation of caveolin-1 expression in Schwann cells via p75 neurotrophin receptor signaling. J Biol Chem 278:23151-23162.
47. Thippeswamy T, McKay JS, Morris R, Quinn J, Wong LF, Murphy D. 2005. Glial-mediated neuroprotection: Evidence for the protective role of the NO-cGMP pathway via neuron-glial communication in the peripheral nervous system. Glia 49:197-210.
48. Tomlinson DR, Fernyhough P, Diemel LT. 1997. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 46:S43-S49.
49. Tosaki T, Kamiya H, Yasuda Y, Naruse K, Kato K, Kozakae M, Nakamura N, Shibata T, Hamada Y, Nakashima E, Oiso Y, Nakamura J. 2008. Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons. Exp Neurol 213:381-387.
50. Toth C, Brussee V, Cheng C, Zochodne DW. 2004. Diabetes mellitus and the sensory neuron. J Neuropathol Exp Neurol 63:561-573.
51. Toth CC, Willis D, Twiss JL, Walsh S, Martinez JA, Liu WQ, Midha R, Zochodne DW. 2009. Locally synthesized calcitonin gene-related Peptide has a critical role in peripheral nerve regeneration. J Neuropathol Exp Neurol 68:326-337.
52. Uziyel Y, Hall S, Cohen J. 2000. Influence of laminin-2 on Schwann cell-axon interactions. Glia 32:109-121.
53. Wanner IB, Guerra NK, Mahoney J, Kumar A, Wood PM, Mirsky R, Jessen KR. 2006. Role of N-cadherin in Schwann cell precursors of growing nerves. Glia 54:439-459.
54. Wood PM, Bunge RP. 1975. Evidence that sensory axons are mitogenic for Schwann cells. Nature 256:662-664.
55. Yamamoto M, Sobue G, Li M, Arakawa Y, Mitsuma T, Kimata K. 1993. Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and low-affinity nerve growth factor receptor (LNGFR) mRNA levels in cultured rat Schwann cells; differential time- and dose-dependent regulation by cAMP. Neurosci Lett 152:37-40.
56. Yoon C, Korade Z, Carter BD. 2008. Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype. J Neurosci 28:3738-3746.
57. Zhang L, Yu C, Vasquez FE, Galeva N, Onyango I, Swerdlow RH, Dobrowsky RT. 2010. Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. J Proteome Res 9:458-471.
58. Zhu H, Yu WJ, Le Y, Wang WJ, Li F, Gui T, Wang YM, Shi WD, Ding WL, Fan XQ. 2012. High glucose levels increase the expression of neurotrophic factors associated with p-p42/p44 MAPK in Schwann cells in vitro. Mol Med Report 6:179-184.
59. Zochodne DW. 2007. Diabetes mellitus and the peripheral nervous system: Manifestations and mechanisms. Muscle Nerve 36:144-166.
60. Zochodne DW. 2008. Diabetic polyneuropathy: An update. Curr Opin Neurol 21:527-533.
61. Zochodne DW, G Said . 1998. Recombinant human nerve growth factor and diabetic polyneuropathy. Neurology 51:662-663.